Accession PRJCA011464
Title Biomarkers for patients with project BL-M01D1-102
Relevance Medical
Data types biomarkers
Organisms Homo
Description The biomarkers of patients in BL-M01D1-102 were analyzed and managed
Sample scope Blood
Release date 2022-08-26
Grants
Agency program Grant ID Grant title
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Biomarker BL-M02D1-102 Phase I study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M02D1 for injection in patients with locally advanced or metastatic gastrointestinal tumors or other solid tumors
Submitter zhongxue li (lizhongxue@baili-pharm.com)
Organization Sichuan Baili Pharmaceutical Co., Ltd.
Submission date 2022-08-26

Project Data

Resource name Description